Marking — Anonymous #118Q-2056Essay Demo Simulation
Question Navigator
Answered
Current
Unanswered
Critically evaluate the role of SGLT2 inhibitors in HFpEF management. (600 words)
A strong answer addresses mechanism, trial evidence (EMPEROR-Preserved, DELIVER), safety, and application to the case, acknowledging limitations.
Heart failure with preserved ejection fraction involves impaired relaxation and increased stiffness of the left ventricle, leading to elevated filling pressures. The raised JVP and bilateral oedema reflect volume overload. Diuretics such as furosemide relieve congestion. SGLT2 inhibitors have emerging evidence in HFpEF, reducing heart failure hospitalisations. Management also includes controlling blood pressure and rate control of atrial fibrillation..
Trial evidence: Addresses Criterion 2 with relevant evidence
Safety: Claim is asserted but not supported
AI-generated annotations are editable. The human marker is accountable for the final score. Both AI and final decisions are audited. (Demo Simulation)
AI Marking Assistant
AI Proposed Score
14 / 14
Confidence
82%
Within confidence threshold.
Rubric Criteria
Mechanism/ 3
Trial evidence/ 4
Safety/ 4
Application to case/ 3
Marker Score
/ 14Agreed
Decision: Pending